retatrutide phase 3 trials Today, we shared new data from two of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide for weight loss: Study

2025;8(3):e250802

Use promptly after reconstitution, or aliquot and store at -80C to preserve peptide activity across multiple experimental uses

In Mar26, BMS Sotyktu (Deucravacitinib) wins FDA approval to treat adults with active psoriatic arthritis (PsA) Total Revenue: $48.67B Founded Year: 1923 Total Employees: 69,200 Headquarters: Bagsvaerd, Denmark Market Cap: $127.23B Stock Exchange: CPH Novo Nordisk is a global healthcare company focused on diabetes, obesity, and rare diseases, with a strong leadership position in metabolic disorders driven by its GLP-1based therapies and innovation-led pipeline

And most importantly, consult your doctor before trying any health supplement you see on social media.